Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$15,609,771.00
Mar 23, 2018
Academia
15090
15090
Establish a western Canadian vaccine manufacturing facility
$50,000,000.00
Apr 1, 2021
Academia
Phase 2 payments for FHB
500000974
To provide financial support to self-employed harvesters who were not eligible for other financial relief programs
$498,000.00
May 1, 2025
For-profit organization
UK Biomanufacturing - 10140683 - H5Nx Vaccine - Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles
1032265
“As part of the international consortium project “H5Nx Vaccine: Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles”, this project proposes to develop a groundbreaking biomanufacturing platform for a novel pan-H5Nx mRNA vaccine.
$500,000.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161625
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2.
$496,871.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161628
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2.
$495,000.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161626
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2.
$496,134.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161633
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2.
$404,547.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161623
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2.
$499,800.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161629
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2.
$434,655.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161631
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2.